140 related articles for article (PubMed ID: 6391995)
1. Non-uniform distribution of islet amyloid in the pancreas of 'maturity-onset' diabetic patients.
Clark A; Holman RR; Matthews DR; Hockaday TD; Turner RC
Diabetologia; 1984 Nov; 27(5):527-8. PubMed ID: 6391995
[TBL] [Abstract][Full Text] [Related]
2. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.
Clark A; Wells CA; Buley ID; Cruickshank JK; Vanhegan RI; Matthews DR; Cooper GJ; Holman RR; Turner RC
Diabetes Res; 1988 Dec; 9(4):151-9. PubMed ID: 3073901
[TBL] [Abstract][Full Text] [Related]
3. Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians.
Clark A; Saad MF; Nezzer T; Uren C; Knowler WC; Bennett PH; Turner RC
Diabetologia; 1990 May; 33(5):285-9. PubMed ID: 2198187
[TBL] [Abstract][Full Text] [Related]
4. Islet amyloid polypeptide: demonstration of mRNA in human pancreatic islets by in situ hybridization in islets with and without amyloid deposits.
Westermark GT; Christmanson L; Terenghi G; Permerth J; Betsholtz C; Larsson J; Polak JM; Westermark P
Diabetologia; 1993 Apr; 36(4):323-8. PubMed ID: 8477877
[TBL] [Abstract][Full Text] [Related]
5. Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals.
Westermark P; Wilander E; Westermark GT; Johnson KH
Diabetologia; 1987 Nov; 30(11):887-92. PubMed ID: 3328723
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic pathology in non-insulin dependent diabetes (NIDDM).
Clark A; de Koning EJ; Hattersley AT; Hansen BC; Yajnik CS; Poulton J
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S39-47. PubMed ID: 8529518
[TBL] [Abstract][Full Text] [Related]
7. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus.
Westermark P; Wilander E
Diabetologia; 1978 Nov; 15(5):417-21. PubMed ID: 367856
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes.
Clark A; Matthews DR; Naylor BA; Wells CA; Hosker JP; Turner RC
Diabetes Res; 1987 Feb; 4(2):51-5. PubMed ID: 2884060
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of type 2 diabetes in Alzheimer disease.
Janson J; Laedtke T; Parisi JE; O'Brien P; Petersen RC; Butler PC
Diabetes; 2004 Feb; 53(2):474-81. PubMed ID: 14747300
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in distribution of amyloid-positive islets in type-2 diabetic patients.
Borromeo CM; Pottier X; In't Veld PA; Pipeleers-Marichal MA; Kaufman L; Pipeleers DG; Van Schravendijk CF
Virchows Arch; 2005 Mar; 446(3):232-8. PubMed ID: 15791482
[TBL] [Abstract][Full Text] [Related]
11. Higher islet amyloid load in men than in women with type 2 diabetes mellitus.
Zhao HL; Sui Y; Guan J; He L; Lai FM; Zhong DR; Yang D; Baum L; Tong PC; Tomlinson B; Chan JC
Pancreas; 2008 Oct; 37(3):e68-73. PubMed ID: 18815541
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population.
de Koning EJ; Bodkin NL; Hansen BC; Clark A
Diabetologia; 1993 May; 36(5):378-84. PubMed ID: 8314440
[TBL] [Abstract][Full Text] [Related]
13. Localisation of islet amyloid polypeptide and its carboxy terminal flanking peptide in islets of diabetic man and monkey.
Clark A; Lloyd J; Novials A; Hutton JC; Morris JF
Diabetologia; 1991 Jun; 34(6):449-51. PubMed ID: 1884903
[TBL] [Abstract][Full Text] [Related]
14. Pancreas Atrophy and Islet Amyloid Deposition in Patients With Elderly-Onset Type 2 Diabetes.
Xin A; Mizukami H; Inaba W; Yoshida T; Takeuchi YK; Yagihashi S
J Clin Endocrinol Metab; 2017 Sep; 102(9):3162-3171. PubMed ID: 28505316
[TBL] [Abstract][Full Text] [Related]
15. Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of severely insulin-deficient diabetes mellitus with atrophied exocrine pancreas.
Sugawara K; Kobayashi T; Nakanishi K; Kajio H; Ohkubo M; Sugimoto T; Murase T; Itoh T; Hara M; Kosaka K
Pancreas; 1993 May; 8(3):312-5. PubMed ID: 8483872
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinicopathological characteristics of islet amyloid in chinese patients with type 2 diabetes.
Zhao HL; Lai FM; Tong PC; Zhong DR; Yang D; Tomlinson B; Chan JC
Diabetes; 2003 Nov; 52(11):2759-66. PubMed ID: 14578294
[TBL] [Abstract][Full Text] [Related]
17. Islet Amyloid in Patients With Diabetes Due to Exocrine Pancreatic Disorders, Type 2 Diabetes, and Nondiabetic Patients.
Ueberberg S; Nauck MA; Uhl W; Montemurro C; Tannapfel A; Clark A; Meier JJ
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32271378
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical localisation of caspase-3 in pancreatic islets from type 2 diabetic subjects.
Tomita T
Pathology; 2010; 42(5):432-7. PubMed ID: 20632819
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment.
de Koning EJ; Fleming KA; Gray DW; Clark A
J Pathol; 1995 Feb; 175(2):253-8. PubMed ID: 7738722
[TBL] [Abstract][Full Text] [Related]
20. Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects.
Clark A; Edwards CA; Ostle LR; Sutton R; Rothbard JB; Morris JF; Turner RC
Cell Tissue Res; 1989 Jul; 257(1):179-85. PubMed ID: 2546670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
